MedTrace Logo

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

NCT01146444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-03-09

No results posted yet for this study

Summary

Part I: to investigate the efficacy of different sunscreens in the prevention of skin lesions following standardized photoprovocation with Ultraviolet A/Ultraviolet B (UVA/UVB) light in patients with CLE.

Part II: to evaluate the influence of different sunscreens on the expression of biomarkers in the skin of patients with CLE and of Healthy Controls following UV irradiation.

Conditions

  • Cutaneous Lupus Erythematosus

Interventions

OTHER

UV A and B irradiation

UV irradiation

Sponsors & Collaborators

  • Spirig Pharma Ltd.

    lead INDUSTRY

Principal Investigators

  • Annegret Kuhn, MD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-09-30
Completion
2012-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01146444 on ClinicalTrials.gov